William Sandborn
0000-0002-3314-7960
3 papers found
Refreshing results…
Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study
Long-term safety of vedolizumab for inflammatory bowel disease
High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis
Missing publications? Search for publications with a matching author name.